4//SEC Filing
Faga Daniel 4
Accession 0001415889-25-001034
CIK 0001370053other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 5:27 PM ET
Size
19.7 KB
Accession
0001415889-25-001034
Insider Transaction Report
Form 4
ANAPTYSBIO, INCANAB
Faga Daniel
DirectorPresident, CEO
Transactions
- Exercise/Conversion
Common Stock
2025-01-03+34,678→ 438,036 total - Tax Payment
Common Stock
2025-01-03$14.60/sh−13,033$190,282→ 425,003 total - Exercise/Conversion
Common Stock
2025-01-06+17,850→ 442,853 total - Tax Payment
Common Stock
2025-01-06$15.30/sh−6,387$97,721→ 436,466 total - Exercise/Conversion
Restricted Stock Unit
2025-01-03−34,678→ 104,032 total→ Common Stock (34,678 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-01-06−17,850→ 35,700 total→ Common Stock (17,850 underlying) - Award
Restricted Stock Unit
2025-01-07+107,350→ 107,350 total→ Common Stock (107,350 underlying) - Award
Stock Option (right to buy)
2025-01-07+305,500→ 305,500 totalExercise: $14.83Exp: 2035-01-06→ Common Stock (305,500 underlying)
Footnotes (8)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- [F2]Reflects the acquisition of 212 shares acquired under the Company's ESPP.
- [F3]Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation.
- [F4]The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes.
- [F5]The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F6]The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F7]The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F8]The stock option vests as to 25% of the total shares on January 7, 2026, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
ANAPTYSBIO, INC
CIK 0001370053
Entity typeother
Related Parties
1- filerCIK 0001673528
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 5:27 PM ET
- Size
- 19.7 KB